Companies Dominating the Psoriasis Treatment Landscape
- LEO Pharma A/S
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- UCB S.A.
- Merck & co. Inc.
- Evelo Biosciences Inc.
- Sun Pharmaceutical Industries ltd.
- Johnson & Johnson Services Inc.
- Navartis AG
- AbbVie Inc.
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Psoriasis Treatment Market in 2025 is estimated at USD 32.8 million.
The global market size surpassed USD 30.67 million in 2024 and is projected to witness a CAGR of over 8.7%, crossing USD 90.72 million revenue by 2037.
North America is set to achieve largest share by 2037, attributed to strong presence of well-equipped infrastructure and rising investment in healthcare.
The major players in the market include LEO Pharma A/S, Amgen Inc., UCB S.A., Merck & co. Inc., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd., Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.
